PROTAC-Based Influenza Treatment Raises Survival in H1N1-Infected Mice to 90%
A PROTAC-based molecule called “Nb-PROTACs” has been developed that increased the survival rate of H1N1 virus-infected mice to 90%. The compound degrades viral nucleoprotein and produced an 80% survival rate in mice infected with H5N1. Its effectiveness against 16 types of influe
2026-05-20


